Cerebral Microbleeds in Different Brain Regions and Their Associations With the Digital Clock-Drawing Test: Secondary

Samia C Akhter-Khan1,2, Qiushan Tao2,3, Ting Fang Alvin Ang2,4,5,6

  • 1Department of Global Health & Social Medicine, King's College London, London, United Kingdom.

Abstract

Insights

The digital clock-drawing test (DCT) can identify cerebral microbleeds (CMB), a risk factor for Alzheimer disease. This accessible cognitive assessment shows promise for early CMB detection, especially deep and mixed types, aiding primary care screening.

Area of Science:

  • Neurology
  • Neuroimaging
  • Cognitive Science

Background:

  • Cerebral microbleeds (CMB) are linked to increased Alzheimer disease risk.
  • Current neuroimaging methods for CMB detection are expensive and not widely accessible.

Purpose of the Study:

  • To investigate the digital clock-drawing test (DCT) as a potential behavioral indicator for cerebral microbleeds (CMB).

Main Methods:

  • Analysis of Framingham Heart Study offspring cohort data, including brain MRI for CMB and DCT.
  • Exclusion of individuals with dementia or stroke history.
  • Application of multivariable linear regression and ROC curve analyses to assess the association between DCT scores and CMB prevalence.

Main Results:

  • 6.27% of 1020 participants had CMB; they were older and had higher rates of mild cognitive impairment.
  • CMB presence was associated with lower overall DCT scores (P=.009).
  • Deep CMB correlated with lower drawing efficiency (P=.01) and simple motor scores (P=.003) on the DCT. ROC analysis showed high accuracy for subtype discrimination (AUC up to 0.98).

Conclusions:

  • The DCT demonstrates significant associations with CMB, particularly deep and mixed types.
  • Reduced performance in drawing efficiency and motor skills on the DCT may indicate CMB.
  • The DCT offers a promising, accessible tool for early CMB detection and cognitive screening in primary care settings.

Related Concept Videos